Dosing levels for pediatric head CTs as recommended by the ACR are met by most hospitals in the U.S.
Most hospitals report doses that meet American College of Radiology accreditation levels for pediatric head CTs, according to a study published in the American Journal of Roentgenology.
Researchers from University of Washington in Seattle and Washington State University College of Nursing Spokane, and Emory University in Atlanta, GA sought to determine the variation of radiation dose CT dose index volume (CTDIvol), and dose-length product (DLP) for pediatric head CT examinations as a function of hospital characteristics across the United States.
A survey with questions about the use of MDCT scanners, dedicated pediatric CT protocols, and dose values was sent to a representative sample (751) of hospitals across the country. A total of 292 responded and 253 were eligible.
The results showed that most of the hospitals that responded (99.2%) used MDCT scanners and most (93%) had a dedicated pediatric protocol. Estimated mean reported CTDIvol values were 27.3 mGy and DLP values were 390.9 mGy × cm. There was no significant variation in values when taking into account region, trauma level, teaching status, CT accreditation, number of CT scanners, or report of a dedicated pediatric CT protocol, the researchers noted. They did find, however, that estimated CTDIvol reported by children's hospitals was 19% lower than that reported by general hospitals.
The researchers concluded that 82% of hospitals surveyed met the ACR accreditation levels, but mean CTDIvol at pediatric facilities was lower than at adult facilities.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.